Neuroprotection in Cerebral Ischemia Open access Peer reviewed

Lycium barbarum polysaccharides protect ischemic brain injury through regulating RPLP1 expression on ischemia-reperfusion nerve cells

Na Shao, Boya Ma, Yi Li, Xu Wang and 1 more

Scientific Reports | Oct 27, 2026

Scollr summary

What this paper is about

It is demonstrated that LBP significantly inhibits apoptosis in ischemic-reperfused neurons, and mechanistic studies revealed that the neuroprotective effects of LBP may be mediated through the Akt/mTOR signaling pathway, which plays a crucial role in cell survival and metabolism.

Full abstract

Read the full abstract

Abstract Ischemic stroke is a major neurological disorder characterized by the sudden interruption of blood flow to the brain, leading to neuronal injury and death. This study investigates the protective effects of lycium barbarum polysaccharides (LBP) on neurons subjected to ischemia-reperfusion injury and its regulatory role on ribosomal protein lateral stalk subunit P1 (RPLP1) expression. Using in vitro cell models, we demonstrated that LBP significantly inhibits apoptosis in ischemic-reperfused neurons. Additionally, LBP treatment resulted in a notable upregulation of RPLP1 expression, indicating its potential to restore ribosomal function compromised during ischemic events. Further mechanistic studies revealed that the neuroprotective effects of LBP may be mediated through the Akt/mTOR signaling pathway, which plays a crucial role in cell survival and metabolism. These findings suggest that LBP not only enhances neuronal viability but also promotes recovery by modulating key cellular pathways involved in neuroprotection. Our results highlight the therapeutic potential of LBP as a candidate for ischemic stroke management, providing insights into its mechanisms of action and paving the way for future research aimed at developing effective interventions for ischemic brain injury.

Direct answer

What can I do from this paper page?

Use this page to scan "Lycium barbarum polysaccharides protect ischemic brain injury through regulating RPLP1 expression on ischemia-reperfusion nerve cells" quickly: start with the summary and abstract, then check the authors, source, topics, and related papers. From here, open Scollr to follow Neuroprotection in Cerebral Ischemia research, save the paper, or map adjacent work.

Authors

Researchers on this paper

Na Shao

first | Ningxia Medical University

Boya Ma

middle | Ningxia Medical University

Yi Li

middle | Ningxia Medical University

Xu Wang

middle | Ningxia Medical University

Du Yarui

last

Research areas

Follow related topics

Citation

BibTeX

@article{Shao2026Lycium,
  title = {Lycium barbarum polysaccharides protect ischemic brain injury through regulating RPLP1 expression on ischemia-reperfusion nerve cells},
  author = {Na Shao and Boya Ma and Yi Li and Xu Wang and Du Yarui},
  journal = {Scientific Reports},
  year = {2026},
  doi = {10.1038/s41598-026-63504-0},
  url = {https://doi.org/10.1038/s41598-026-63504-0}
}

FAQ

Using this paper in a discovery workflow

How do I find related work for this paper?

Use the related papers and topic links on this page as starting points. In Scollr, you can also open the paper and build a literature map around its references, citing papers, and related work.

How can I keep up with new Neuroprotection in Cerebral Ischemia research papers?

Follow Neuroprotection in Cerebral Ischemia research in Scollr. New papers from the topic flow into a personalized feed, and you can save useful studies to revisit later.

Can I cite this paper from this page?

This page includes a static BibTeX block for Lycium barbarum polysaccharides protect ischemic brain injury through regulating RPLP1 expression on ischemia-reperfusion nerve cells. Always verify the DOI, source, and publication details against the publisher record before submitting a manuscript.

Follow this research in Scollr

Follow the topics and authors behind this paper, save useful studies, and build a literature map when you are ready to go deeper.

Get the app